Envoy Medical, Inc.

Envoy Medical, Inc. (Nasdaq: COCH) is a medical device company specializing in implantable hearing technology, including a fully implantable cochlear system designed for patients with sensorineural hearing loss. The company entered the public markets through a merger with Anzu Special Acquisition Corp I, a blank-check vehicle sponsored by Anzu Partners that completed its IPO in 2021. The de-SPAC business combination closed in September 2023, listing Envoy Medical on Nasdaq under the ticker COCH. On February 6, 2026, the company filed an S-1/A registration statement amendment with the SEC, reflecting ongoing post-merger capital markets activity in the medical device and hearing health sector. Sign up at SpacDesk for complete COCH filing history, sponsor data, and real-time SPAC analytics.